Deloitte Access Economics

The Economic Costs of Crohn's Disease and Ulcerative Colitis

This landmark study commissioned by CCA reveals the $2.7 billion annual cost of Crohn's disease and ulcerative colitis in Australia. The report details the financial costs and economic burden caused by these chronic illnesses. The study also recommends a strategy to reduce the costs associated with IBD and enhance the quality and options for care and disease management.

Download the full report: Economic Costs of Crohn's Disease and Ulcerative Colitis

Download a two page summary of the Report